Jiayun Fu , Xiaoqian Tang , Du Wang , Qi Zhang , Jinsheng Duan , Peiwu Li
{"title":"Advancements of immunoassay technology based on nanobodies","authors":"Jiayun Fu , Xiaoqian Tang , Du Wang , Qi Zhang , Jinsheng Duan , Peiwu Li","doi":"10.1016/j.biotechadv.2025.108776","DOIUrl":null,"url":null,"abstract":"<div><div>Nanobodies (Nbs), the single-domain antigen-binding fragments, have emerged as promising biorecognition elements for immunoassays due to their small size, high stability, strong affinity, and ease of engineering. This review comprehensively summarizes recent advances in Nb-based immunoassay technologies, highlighting their advantages in immunoassay such as phage-displayed Nbs, Nb-reporter fusions, toxin-free substitutes using anti-idiotypic Nbs, reusable immunoaffinity ligands, bispecific Nbs for multi-target detection, and multivalent Nbs to enhance binding avidity. The review further discusses their applications in food safety, clinical diagnostics, and environmental monitoring, highlighting their impact across these fields. Key challenges such as the limited number of available Nbs, low expression levels, and commercialization bottlenecks are discussed, along with emerging solutions like synthetic libraries and computer-aided design. This review aims to provide insights into the development trends and application potential of Nb-based immunoassays, promoting their future advancement in analytical and diagnostic.</div></div>","PeriodicalId":8946,"journal":{"name":"Biotechnology advances","volume":"87 ","pages":"Article 108776"},"PeriodicalIF":14.1000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology advances","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0734975025002629","RegionNum":1,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Nanobodies (Nbs), the single-domain antigen-binding fragments, have emerged as promising biorecognition elements for immunoassays due to their small size, high stability, strong affinity, and ease of engineering. This review comprehensively summarizes recent advances in Nb-based immunoassay technologies, highlighting their advantages in immunoassay such as phage-displayed Nbs, Nb-reporter fusions, toxin-free substitutes using anti-idiotypic Nbs, reusable immunoaffinity ligands, bispecific Nbs for multi-target detection, and multivalent Nbs to enhance binding avidity. The review further discusses their applications in food safety, clinical diagnostics, and environmental monitoring, highlighting their impact across these fields. Key challenges such as the limited number of available Nbs, low expression levels, and commercialization bottlenecks are discussed, along with emerging solutions like synthetic libraries and computer-aided design. This review aims to provide insights into the development trends and application potential of Nb-based immunoassays, promoting their future advancement in analytical and diagnostic.
期刊介绍:
Biotechnology Advances is a comprehensive review journal that covers all aspects of the multidisciplinary field of biotechnology. The journal focuses on biotechnology principles and their applications in various industries, agriculture, medicine, environmental concerns, and regulatory issues. It publishes authoritative articles that highlight current developments and future trends in the field of biotechnology. The journal invites submissions of manuscripts that are relevant and appropriate. It targets a wide audience, including scientists, engineers, students, instructors, researchers, practitioners, managers, governments, and other stakeholders in the field. Additionally, special issues are published based on selected presentations from recent relevant conferences in collaboration with the organizations hosting those conferences.